Single dose versus multiple doses of rituximab for preemptive therapy of Epstein-Barr virus reactivation after hematopoietic cell transplantation.
Leuk Lymphoma
; 60(1): 110-117, 2019 01.
Article
in En
| MEDLINE
| ID: mdl-29979906
Full text:
1
Collection:
01-internacional
Health context:
4_TD
Database:
MEDLINE
Main subject:
Viremia
/
Hematopoietic Stem Cell Transplantation
/
Epstein-Barr Virus Infections
/
Rituximab
/
Lymphoproliferative Disorders
Type of study:
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adolescent
/
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Leuk Lymphoma
Year:
2019
Document type:
Article